Pamidronate used to ameliorate post renal transplant bone loss is not associated with increased renal dysfunction.

被引：0
|
作者：
Lee, S [1 ]
Glicklich, D [1 ]
Coco, M [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：695A / 695A
页数：1
相关论文
共 50 条
  • [21] Calcineurin inhibitor withdrawal and replacement with sirolimus in cardiac transplant recipients with renal dysfunction.
    Kushwaha, SS
    Wilson, JA
    Frantz, RP
    Rodeheffer, RJ
    Clavell, AL
    Daly, RC
    McGregor, CG
    Edwards, BS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 170 - 170
  • [22] Renal dysfunction is associated with increased bone turnover in HIV-infected patients
    Alvarez, E.
    Cotter, A. G.
    Brady, J. J.
    Galvin, C.
    Macken, A.
    Kavanagh, E.
    Sabin, C. A.
    Rodriguez-Novoa, S.
    Mallon, P. W. G.
    ANTIVIRAL THERAPY, 2014, 19 : A17 - A18
  • [23] Serial duplex index improves differential diagnosis of acute renal transplant dysfunction.
    Meier, Markus
    Eikenbusch, Katrin
    Kramer, Jan
    Suefke, Sven
    Jabs, Wolfram J.
    Fricke, Lutz
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 355 - 355
  • [24] Cardiac diastolic dysfunction in renal-transplant recipients is associated with increased circulating Adrenomedullin
    Geny, Bernard
    Ellero, Bernard
    Chakfe, Nabil
    Kretz, Jean-George
    Brandenberger, Gabrielle
    Piquard, Francois
    CLINICAL TRANSPLANTATION, 2006, 20 (03) : 330 - 335
  • [25] Morphometric analysis on mitochondrial abnormality in mitochondrial myopathy associated with renal dysfunction.
    Ishikawa, Y
    Joh, K
    Aizawa, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1830 - A1830
  • [26] Levels of VEGF-C, PLGF and Follistatin at 12 Months Post Transplantation Are Associated with Increased Risk for Long Term Progressive Renal Dysfunction.
    Dreyer, G.
    de Fijter, J.
    Briscoe, D.
    Daly, K.
    Reinders, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 313 - 314
  • [27] Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation
    Nam, JH
    Moon, JI
    Chung, SS
    Kim, SI
    Park, KI
    Song, YD
    Kim, KR
    Lee, HC
    Huh, K
    Lim, SK
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1876 - 1876
  • [28] Risk of End-Stage Renal Disease after Liver Transplant among Recipients with Sustained Pre-Transplant Renal Dysfunction.
    Goldberg, D.
    Ruebner, R.
    Bahirwani, R.
    Abt, P.
    Levine, M.
    Sawinski, D.
    Bloom, R.
    Reese, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 513 - 514
  • [29] Successful decrease of IL-2 inhibitors in liver transplant patients with renal dysfunction.
    Stieber, AC
    Smallwood, GA
    Lin, A
    Heffron, TG
    TRANSPLANTATION, 2000, 69 (08) : S169 - S169
  • [30] Angiotensin system gene polymorphisms identify patients at risk for chronic renal transplant dysfunction.
    Abdi, R
    Tran, HT
    Zee, R
    Brenner, BM
    Milford, EL
    TRANSPLANTATION, 2000, 69 (08) : S381 - S381
12345